Phosphatidic Acid (Mediator)

Phosphatidic acid is a bioactive phospholipid that directly activates the mTOR (mechanistic target of rapamycin) signaling pathway, stimulating muscle protein synthesis. It functions as a lipid messenger that enhances anabolic processes, leading to increased lean muscle mass and strength gains.

Origin & History

Phosphatidic Acid is a phospholipid found in cell membranes and is involved in signaling pathways that stimulate muscle protein synthesis.

Historical & Cultural Context

While not traditionally used, Phosphatidic Acid has become popular in modern sports nutrition for its anabolic properties.

Health Benefits

- Stimulates muscle protein synthesis, crucial for muscle growth. It activates mTOR signaling, enhancing muscle-building processes. - Increases lean body mass, supporting athletes in achieving a more muscular physique. Studies show a 3% increase in lean mass over 8 weeks. - Enhances strength, allowing for improved performance in resistance training. This is achieved through its role in muscle cell signaling. - Reduces muscle breakdown, preserving muscle tissue during intense training. This is vital for maintaining muscle mass during calorie deficits. - Improves recovery by accelerating muscle repair processes. This enables athletes to train harder and more frequently. - Supports fat loss by maintaining muscle mass, which is essential for a healthy metabolism. - Enhances endurance, allowing athletes to sustain longer training sessions.

How It Works

Phosphatidic acid directly binds to and activates mTOR Complex 1 (mTORC1) by displacing the inhibitory protein FKBP12-rapamycin binding domain. This activation triggers downstream signaling through p70S6K1 and 4E-BP1 pathways, which initiate ribosomal protein S6 phosphorylation and eIF4E release. The result is enhanced translation initiation and increased muscle protein synthesis rates.

Scientific Research

Research, including some clinical trials, suggests Phosphatidic Acid can enhance muscle growth when combined with resistance training.

Clinical Summary

Human studies using 750mg daily phosphatidic acid supplementation show 3% increases in lean body mass over 8 weeks in resistance-trained individuals. A randomized controlled trial with 28 participants demonstrated significant improvements in squat and bench press strength compared to placebo. Additional research indicates enhanced muscle thickness measurements via ultrasound after 8 weeks of supplementation. However, the total number of human studies remains limited, with most research conducted on small sample sizes of 20-30 participants.

Nutritional Profile

Phosphatidic Acid (PA) is a glycerophospholipid, not a traditional macronutrient or micronutrient source. Typical supplemental doses range from 250–750 mg/day, with 750 mg being the most studied dose in human trials. As a phospholipid, it contains a glycerol backbone, two fatty acid chains (commonly palmitic C16:0 and oleic C18:1 in soy-derived PA), and a phosphate head group. Caloric contribution is negligible at supplemental doses (~6–7 kcal per 750 mg dose, primarily from fatty acid chains). Macronutrient breakdown per 750 mg serving: lipid content ~750 mg (predominantly phospholipid-bound fatty acids), protein content ~0 g, carbohydrate content ~0 g. Key bioactive compound: phosphatidic acid itself, acting as a lipid second messenger that directly binds to and activates mTORC1 (mechanistic target of rapamycin complex 1) via the FKBP12-rapamycin binding (FRB) domain. Soy-derived PA (the most common commercial source, e.g., Mediator brand by Chemi Nutra) contains approximately 50% PA by weight with remaining phospholipid fractions (phosphatidylcholine, phosphatidylinositol as minor components). Bioavailability: PA is hydrolyzed in the gut to lysophosphatidic acid (LPA) and diacylglycerol (DAG), both of which can be re-synthesized into PA intracellularly; direct intestinal absorption of intact PA molecules is limited but measurable. No significant vitamin or mineral content is present at supplemental doses.

Preparation & Dosage

Common dosages range from 250 to 750 mg per day. Consult a healthcare provider before use.

Synergy & Pairings

Creatine, Whey Protein, BCAAs

Safety & Interactions

Phosphatidic acid appears well-tolerated at standard dosages of 750mg daily with no serious adverse effects reported in clinical trials. Minor gastrointestinal discomfort may occur in sensitive individuals, particularly when taken on an empty stomach. No significant drug interactions have been documented, though theoretical concerns exist with immunosuppressive medications due to mTOR pathway involvement. Pregnancy and breastfeeding safety data are insufficient, so use should be avoided during these periods.